Wikipedia
Isatuximab
Isatuximab is a monoclonal antibody (mAb) designed for the treatment of cancer.
Previously known as SAR650984, it is an anti- CD38 mAb intended to treat relapsed or refractory multiple myeloma.
This drug was developed by Sanofi-Aventis.